Clinical and Diagnostic Laboratory Immunology, October 2005, p. 1243-1245, Vol. 12, No. 10
1071-412X/05/$08.00+0 doi:10.1128/CDLI.12.10.1243-1245.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Immunogenicity of an Intranasally Administered Modified Live Canine Parvovirus Type 2b Vaccine in Pups with Maternally Derived Antibodies
Vito Martella,*
Alessandra Cavalli,
Nicola Decaro,
Gabriella Elia,
Costantina Desario,
Marco Campolo,
Giancarlo Bozzo,
Elvira Tarsitano, and
Canio Buonavoglia
Department of Animal Health and Well-Being, Faculty of Veterinary Medicine, University of Bari, S.p. per Casamassima km 3, 70010 Valenzano, Bari, Italy
Received 17 May 2005/
Returned for modification 11 July 2005/
Accepted 19 July 2005
The ability of a modified live canine parvovirus type 2b vaccine to elicit active immunization in pups with maternally derived antibodies (MDA) by intranasal administration was evaluated. The vaccine induced seroconversion in 100% of pups with MDA titers of
80 and in 51.6% of pups with titers between 160 and 320.
* Corresponding author. Mailing address: Dipartimento di Sanità e Benessere Animale, Facoltà di Medicina Veterinaria, Università di Bari, S.p. per Casamassima km 3, 70010 Valenzano, Bari, Italy. Phone: 39 080 4679805. Fax: 39 080 4679043. E-mail: v.martella{at}veterinaria.uniba.it.
Clinical and Diagnostic Laboratory Immunology, October 2005, p. 1243-1245, Vol. 12, No. 10
1071-412X/05/$08.00+0 doi:10.1128/CDLI.12.10.1243-1245.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Copyright © 2005 by the American Society for Microbiology. All rights reserved.